SCHEMBL7555496

SCHEMBL7555496

CNc1cc(COCCN)cc(OC)c1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 2/20 0.37
TAAR1 Q96RJ0 3/20 0.37
IDO1 P14902 2/20 0.33
AGXT P21549 2/20 0.33
CYP19A1 P11511 1/20 0.33
MAOB P27338 3/20 0.33
ABCB1 P08183 1/20 0.33
POLB P06746 1/20 0.33
KMT2A Q03164 1/20 0.33
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2A Q12879 1/20 0.33
GRIN2B Q13224 1/20 0.33
GRIN2C Q14957 1/20 0.33
GRIN3A Q8TCU5 1/20 0.33
CALM1 P0DP23 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2937484 0.86 ALDH1A1 (0.44) TACR1TAAR1IDO1AGXTCYP19A1
SCHEMBL15023472 0.79 IDO1 (0.40) TACR1TAAR1IDO1AGXTCYP19A1
SCHEMBL14668896 0.75 TDP1 (0.43) TACR1TAAR1IDO1AGXTCYP19A1
SCHEMBL5132384 0.74 DAO (0.41) POLBKMT2AGRIN2DGRIN3BGRIN1
SCHEMBL7545303 0.72 CYP11B1 (0.40) TAAR1MAOBGRIN1GRIN2B
SCHEMBL1547868 0.72 ALDH1A1 (0.61) POLBKMT2A
SCHEMBL10373698 0.72 IDO1 (0.32) TAAR1IDO1
SCHEMBL11243873 0.72 IDO1 (0.59) TAAR1IDO1AGXTMAOB
SCHEMBL7889540 0.70 ALDH1A1 (0.58) TACR1IDO1AGXTCYP19A1ABCB1
Hydrochloric Acid SCHEMBL9370865 0.70 KDM4E (0.36) TAAR1IDO1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1214288-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE Targacept Inc. (US) 2002-06-19 EP disclosed
WO-2001017943-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE TARGACEPT, INC. (US) 2001-03-15 WO disclosed
EP-1042274-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE R.J. REYNOLDS TOBACCO COMPANY (US) 2000-10-11 EP disclosed
WO-2000023418-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE R.J. REYNOLDS TOBACCO COMPANY (US) 2000-04-27 WO disclosed